Myomo to Report First Quarter Financial Results on May 14, 2020
CAMBRIDGE, Mass. (May 12, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2020 on Thursday, May 14, 2020 […]
Myomo Reports Accelerating Growth in MyoPro Pipeline and Record Backlog in the First Quarter of 2020, Provides Update on the Business Impact of COVID-19
CAMBRIDGE, Mass. (April 8, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported its pipeline of MyoPro candidates continued to grow during the first quarter of 2020, with more than 700 candidates awaiting […]
Myomo, Inc., to Present at the New York City based Investor Summit on March 25th-26th
NEW YORK, NY / ACCESSWIRE / March 18, 2020 / Myomo, Inc. (NYSE American:MYO) – A wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will be presenting at this year’s Spring Investor Summit on March 25th-26th. Read more.
Myomo Reports 2019 Fourth Quarter and Full Year Financial Results Featuring Record Revenue and Gross Margins
Direct Billing Represents 50% of Fourth Quarter Revenue CAMBRIDGE, Mass. (March 12, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the fourth quarter and year ended December 31, 2019. […]
Myomo to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020
Management to host Financial Results Conference Call at 4:15 p.m. ET CAMBRIDGE, Mass. (March 5, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the […]
MYOMO ANNOUNCES CLOSING OF PUBLIC OFFERING
CAMBRIDGE, MA., February 19, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”) a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the closing of its previously announced underwritten public offering of 2,143,000 shares of common stock or common stock equivalents […]
Myomo® Signs Nationwide Payer Network Agreement with HOMELINK
Enables Myomo to Bill “In-network” with 1200 Payers CAMBRIDGE, Mass., February 19, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with HOMELINK which will enable […]
MYOMO ANNOUNCES PRICING OF PUBLIC OFFERING
CAMBRIDGE, Mass., February 11, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”) a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of an underwritten public offering of 2,143,000 shares of common stock or common stock equivalents (which includes […]
Myomo Reports Preliminary Fourth Quarter and Full Year 2019 Results
CAMBRIDGE, MA., February 6, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced preliminary financial and operational results for the fourth quarter and fiscal year ended December 31, 2019. Read more.
Myomo Not Aware of Any Developments to Account for Stock Volatility
CAMBRIDGE, Mass., February 5, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it is unaware of any developments concerning the business of the Company that could account for the recent […]